Ketoconazole in the treatment of chronic mucocutaneous candidiasis secondary to autoimmune polyendocrinopathy-candidiasis syndrome.
D000293:Adolescent; D000935:Antifungal Agents / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000276:immunology; D002177:Candidiasis / Q000188:drug therapy*; D002178:Candidiasis, Chronic Mucocutaneous / Q000188:drug therapy* / Q000276:immunology; D004700:Endocrine System Diseases / Q000276:immunology; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007654:Ketoconazole; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D013577:Syndrome
D000935:Antifungal Agents; D007093:Imidazoles; D010879:Piperazines; D007654:Ketoconazole